Jack Khattar | executive |
Timothy Dec | executive |
Lin Tsai | analyst |
David Amsellem | analyst |
Stacy Ku | analyst |
Jack Padovano | analyst |
Good afternoon, and welcome to the Supernus Pharmaceuticals Fourth Quarter and Full Year 2023 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Vozzo of ICR Westwicke, Investor Relations representative for Supernus Pharmaceuticals.
You may begin.
Thank you, Rebecca.